Nest Genomics

Nest Genomics offers a comprehensive digital health/software platform that enables healthcare organizations to integrate genetic testing and longitudinal genomic data into routine clinical care. The solution supports hereditary cancer/cardiovascular genetics programs and conditions from ACMG’s secondary findings list. It provides EMR integration for provider workflows as well as patient-facing tools. The company has raised $8.5M+ in seed funding from top investors including B Capital and Y Combinator. Its founders previously built Clear Genetics (acquired by Invitae). Customers include several large US health systems; further specialty areas such as pediatrics and pharmacogenetics are planned expansions.